Abstract:Decrease of 'health-benefiting' microbes and increase of pathogenic bacteria (a condition termed dysbiosis) in intensive care unit patients is considered to induce or aggravate sepsis (gut-origin sepsis). Orally administered probiotics have been effective in the prevention of nosocomial infections. However, the mechanisms of probiotic-induced anti-infection and anti-sepsis remain to be explored. In the present study, 4-week-old C57BL6 mice were orally administrated with Lactobacillus rhamnosus GG (LGG) or normal saline (control) 4 weeks prior to cecal ligation and puncture (CLP). A subset of the mice were sacrificed at 24 h post-CLP, and the others were used for survival studies. Ileum tissues, blood and fecal samples were collected. The survival rate of septic mice pretreated with LGG was significantly improved compared with untreated mice. The levels of inflammatory cytokines were reduced in LGG-pretreated septic mice. A decrease of colonic proliferation and epithelial tight junctions and an increase of colonic apoptosis were observed in control septic CLP+saline mice. LGG pretreatment reversed the colonic proliferation, apoptosis and expression of tight junction proteins to the levels of the sham group. LGG pretreatment improved the richness and diversity of intestinal microbiota in septic mice. The principal coordinates analysis clustering plots revealed a significant separate clustering in microbiota structure between three groups. Bacteria associated with energy consumption, including Bacteroidetes, with opportunistic infection, including Proteobacteria, Staphylococcaceae and Enterococcaceae, lipopolysaccharide producers, including Enterobacteriaceae, and facultative anaerobes, such as Bacteroidaceae and Erysipelotrichaceae, increased in septic mice. By contrast, bacteria associated with energy harvest, including Firmicutes, intestinal barrier function regulators, including Akkermansia, hepatic function regulators, including Coprococcus and Oscillospira, and obligate anaerobes, including Prevotellaceae, decreased in septic mice. With LGG pretreatment, the sepsis-induced microbiota dysbiosis was reversed. The present results elucidated the potential mechanism of LGG treatment in sepsis, by improving intestinal permeability and modulating microbiota dysbiosis.

GYY4137 Ameliorates Intestinal Barrier Injury in a Mouse Model of Endotoxemia.

Lactobacillus Rhamnosus Gg Treatment Improves Intestinal Permeability And Modulates Microbiota Dysbiosis In An Experimental Model Of Sepsis

GYY4137, As a Slow-Releasing H2S Donor, Ameliorates Sodium Deoxycholate-Induced Chronic Intestinal Barrier Injury and Gut Microbiota Dysbiosis

GYY4137 Attenuates Sodium Deoxycholate-Induced Intestinal Barrier Injury Both in Vitro and in Vivo

Glucagon-Like Peptide-2 Modulates Enteric Paneth Cells Immune Response and Alleviates Gut Inflammation During Intravenous Fluid Infusion in Mice With a Central Catheter

Changyanning Regulates Gut Microbiota and Metabolism to Ameliorate Intestinal Injury Induced by ETEC K88

Exogenous S-Nitrosoglutathione Attenuates Inflammatory Response And Intestinal Epithelial Barrier Injury In Endotoxemic Rats

<i>Lactobacillus rhamnosus</i> GG Derived Extracellular Vesicles Modulate Gut Microbiota and Attenuate Inflammatory in DSS-Induced Colitis Mice

Berberine Ameliorates Intestinal Epithelial Tight-Junction Damage and Down-Regulates Myosin Light Chain Kinase Pathways in a Mouse Model of Endotoxinemia.

Lactobacillus rhamnosus GG Derived Extracellular Vesicles Modulate Gut Microbiota and Attenuate Inflammatory in DSS-Induced Colitis Mice

GYY4137 alleviates sepsis-induced acute lung injury in mice by inhibiting the PDGFR/Akt/NF-B/NLRP3 pathway

Protective Effect of Electroacupuncture on the Barrier Function of Intestinal Injury in Endotoxemia through HO-1/PINK1 Pathway-Mediated Mitochondrial Dynamics Regulation

Intestinal Recruitment of CCR6-expressing Th17 Cells by Suppressing Mir-681 Alleviates Endotoxemia-Induced Intestinal Injury and Reduces Mortality

Butyrate Glycerides Protect against Intestinal Inflammation and Barrier Dysfunction in Mice

Lactobacillus rhamnosus GG Promotes Recovery of the Colon Barrier in Septic Mice through Accelerating ISCs Regeneration

GYY4137 Ameliorates Sepsis-induced Cardiomyopathy via Inhibiting NLRP3 Inflammasome Activity and Reduction of Oxidative Stress in the Myocardium

Improving Intestinal Barrier Function in Sepsis by Partially Hydrolysed Guar Gum via the Suppression of the NF-κB/MLCK Pathway

Effect of Ginsenoside Fermented by Pediococcus Acidilactici XM-06 on Preventing Diarrhea in Mice Via Regulating Intestinal Barrier Function and Gut Microbiota

Novel Pentapeptide Derived from Chicken By-Product Ameliorates DSS-Induced Colitis by Enhancing Intestinal Barrier Function Via AhR-Induced Src Inactivation

Protective Effects and Mechanisms of Extracts of Gleditsia Sinensis Lam. Thorn on DSS-Induced Colitis in Mice

Protective effect of zinc gluconate on intestinal mucosal barrier injury in antibiotics and LPS-induced mice